Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Highlights

Highlights of This Issue

DOI:  Published November 2015
  • Article
  • Info & Metrics
  • PDF
Loading

Physician HPV Vaccine Communication

Gilkey et al. Page 1673

Gilkey and colleagues sought to describe human papillomavirus (HPV) vaccine communication practices among primary care physicians. Physicians completed a national online survey and the quality of their HPV vaccine recommendations was assessed. A sizeable minority of physicians reported that they do not strongly endorse HPV vaccine (27%). Many physicians (59%) used a risk-based approach to recommending HPV vaccine and only half (51%) usually recommended same-day vaccination. In this national sample, many physicians reported recommending HPV vaccine inconsistently, behind schedule, or without urgency. Efforts to improve physician communication about HPV vaccine will be critical to address the persistent underuse of a powerful tool for cancer prevention.

Breast Cancer Disparities by Subtype

Chen and Li Page 1666

African American and Hispanic women are both more likely to be diagnosed with aggressive forms of breast cancer, but disparities within each breast cancer subtype have not been well documented. Chen and Li used data from 18 SEER cancer registries and identified 102,064 women diagnosed with invasive breast cancer in 2010–2011 with known stage, hormone receptor, and HER2 status. African American and Hispanic women were 30–60% more likely to be diagnosed with stage II–IV breast cancer compared to non-Hispanic whites, and African American women had 40–70% higher risks of stage IV breast cancer across all four subtypes. American Indian/Alaska Native women had a 3.9-fold higher risk of stage IV triple-negative breast cancer. These findings provide important characterization of the subtypes of breast cancer racial/ethnic disparities.

Fine Mapping of 4q24 Region

Guo et al. Page 1680

A common variant (rs9790517) at chromosome position 4q24 has been reported to be associated with breast cancer risk. Guo and colleagues conducted fine-mapping analysis in 55,540 breast cancer cases and 51,168 controls from the Breast Cancer Association Consortium. Conditional analyses identified two independent association signals among women of European ancestry. Functional annotation revealed two putative functional variants in the promoter and enhancer of the gene, TET2. Both variants are located in DNase I hypersensitivity and transcription factor binding sites, suggesting that the observed association in this locus may be mediated through the regulation of TET2.

Metformin Use Reduces Precancerous Lesions

Marks et al. Page 1692

Existing literature suggests that metformin may lower colorectal cancer (CRC) risk. Because most CRC originates in precancerous adenomas, Marks and colleagues examined whether metformin use lowered colorectal adenoma risk after polypectomy in patients with type-2 diabetes. Compared to patients not receiving diabetes medications (n = 1,578), metformin-only use (n = 457) was associated with lower adenoma recurrence risk and the association was stronger with increasing total metformin dose. This study suggests a potential benefit of metformin use in lowering the risk of subsequent adenomas after polypectomy in patients with type-2 diabetes.

  • ©2015 American Association for Cancer Research.
Next
Back to top
Cancer Epidemiology Biomarkers & Prevention: 24 (11)
November 2015
Volume 24, Issue 11
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Highlights of This Issue
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Highlights of This Issue
Cancer Epidemiol Biomarkers Prev November 1 2015 (24) (11) 1641;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Highlights of This Issue
Cancer Epidemiol Biomarkers Prev November 1 2015 (24) (11) 1641;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Physician HPV Vaccine Communication
    • Breast Cancer Disparities by Subtype
    • Fine Mapping of 4q24 Region
    • Metformin Use Reduces Precancerous Lesions
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Selected Articles from This Issue
  • Selected Articles from This Issue
  • Selected Articles from This Issue
Show more Highlights
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement